Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2010-09-01 17:14:36
Reporting Period:
Filing Date:
Accepted Time:
2010-09-01 17:14:36
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Inc JAZZ Pharmaceutical Preparations (2834) 050563787
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193210 C Bruce Cozadd C/o Jazz Pharmaceuticals
3180 Porter Drive
Palo Alto CA 94304
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-08-31 10,000 $8.60 280,181 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.50 to $8.64, inclusive.
  2. The reporting person undertakes to provide to Jazz Pharmaceuticals, Inc., any security holder of Jazz Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4.